These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21448567)

  • 1. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.
    Izidoro-Toledo TC; Guimaraes DA; Belo VA; Gerlach RF; Tanus-Santos JE
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):547-54. PubMed ID: 21448567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of high glucose and atorvastatin on endothelial cell matrix production.
    McGinn S; Poronnik P; Gallery ED; Pollock CA
    Diabet Med; 2004 Oct; 21(10):1102-7. PubMed ID: 15384957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB.
    Lee DK; Park EJ; Kim EK; Jin J; Kim JS; Shin IJ; Kim BY; Lee H; Kim DE
    Cell Physiol Biochem; 2012; 30(3):499-511. PubMed ID: 22814256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
    Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC
    Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of statins on bone mineral density and bone histomorphometry in rodents.
    Maritz FJ; Conradie MM; Hulley PA; Gopal R; Hough S
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1636-41. PubMed ID: 11597938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
    Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H
    J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of interaction between vascular endothelial cells and monocytes on expression of matrix metalloproteinase-2 and of tissue inhibitor of metalloproteinases 2 and regulation of pravastatin].
    Zheng W; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):105-8. PubMed ID: 15842807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
    Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
    Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.
    Stach K; Nguyen XD; Lang S; Elmas E; Weiss C; Borggrefe M; Fischer J; Kälsch T
    Cardiol J; 2012; 19(1):20-8. PubMed ID: 22298164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells.
    Ali OF; Growcott EJ; Butrous GS; Wharton J
    Respir Res; 2011 Oct; 12(1):137. PubMed ID: 21999923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of elastin degradation products, glucose and atorvastatin on metalloproteinase-1, -2, -9 and tissue inhibitor of metalloproteinases-1, -2, -3 expression in human retinal pigment epithelial cells.
    Dorecka M; Francuz T; Garczorz W; Siemianowicz K; Romaniuk W
    Acta Biochim Pol; 2014; 61(2):265-70. PubMed ID: 24904926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice.
    Moustardas P; Kadoglou NP; Katsimpoulas M; Kapelouzou A; Kostomitsopoulos N; Karayannacos PE; Kostakis A; Liapis CD
    PLoS One; 2014; 9(9):e108240. PubMed ID: 25264981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity.
    Tesfamariam B; Frohlich BH; Gregg RE
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):95-101. PubMed ID: 10413074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
    An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
    Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro.
    Salman H; Bergman M; Djaldetti M; Bessler H
    Biomed Pharmacother; 2008 Jan; 62(1):41-5. PubMed ID: 17768028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA
    Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.